POLY MEDICURE LTD. - 531768 - Shareholding for the Period Ended December 31, 2020
Poly Medicure Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here14-01-2021
14-01-2021
POLY MEDICURE LTD. - 531768 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- AVINASH CHANDRADesignation :- Company Secretary and Compliance Officer12-01-2021
POLY MEDICURE LTD. - 531768 - Closure of Trading Window
It may please be noted that in compliance with the SEBI (Prohibition to Insider Trading) Regulations, 2015 as amended by the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 read with clarification given by BSE Circular Ref No.: LIST/COMP/01/2019-20 dated 02.04.2019 and NSE letter ref no: NSE/CML/2019/11 dated 02.04.2019 read with Company''s Code of Conduct for prevention of Insider Trading, the Trading Window of the Company has been kept closed for designated person from Friday, the 1st January, 2021 till the end of 48 hours after the declaration of Financial Results for the quarter and nine months ended on 31st December, 2020. The date of the Board Meeting to consider the above financial results would be intimated to the Stock Exchange in due course. You are hereby requested to please take the above information on your records.31-12-2020
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In addition to our intimation dated 14th December, 2020, we wish to inform that the Company has issued a newspaper advertisement for Postal Ballot under applicable provisions of the Companies Act, 2013, read with relevant rules made thereunder, and other applicable laws & regulations, as amended and in terms of the circulars issued by the Ministry of Corporate Affairs, Government of India vide its General Circular Nos.14/2020 dated April 08,2020, 17/2020 dated April 13, 2020, 22/2020 dated June 15, 2020 and 33/2020 dated September 28, 2020 in view of COVID-19 pandemic ('MCA Circulars'). Please find enclosed herewith the newspaper cuttings of publication for the successful dispatch of Postal Ballot notice published in the following newspapers. Financial Express (English, All Edition) - Published on Tuesday, (15.12.2020) Jansatta (Hindi, All Edition) - Published on Tuesday, (15.12.2020) This is for your information and record.16-12-2020
POLY MEDICURE LTD. - 531768 - Submission Of Postal Ballot Notice Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 30 of the Listing Regulations, please find enclosed Notice of Postal Ballot dated 08.12.2020 sent to the members of the Company at their registered email address for seeking approval for the resolutions as contained in the Notice. Deemed Date of Completion of Dispatch of Notice (by email) to members whose names appear in the member register/ records as on Friday December 11, 2020 ('Cut-off date') is Monday, December 14, 2020. The remote e-voting facility will commence from Tuesday, December 15, 2020 at 09:00 a.m. India Standard Time ('IST') and ends on Wednesday, January 13, 2021 at 05:00 p.m. IST (both days inclusive).The result of the Postal Ballot shall be declared on or before Friday, January 15, 2021. The said information is also available on the Website of the Company. This is for your information, as also for the information of the public at large. Please take the above on record and acknowledge receipt of the same.14-12-2020
POLY MEDICURE LTD. - 531768 - Outcome Of Board Meeting Held On 08Th Decemeber, 2020.
Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 8th December, 2020, at 232-B, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi-110020 has considered and approved the proposal for raising of funds through issuance of new securities by way of Qualified Institutional Placement ('QIP') and seeking approval of the members by way of Special Resolution for the same and in this regard we wish to submit as under:- a) The Board has considered and approved raising of funds to the tune of amount not exceeding INR 400 Crores through new issue of equity shares by way of qualified institutions placement, in accordance with the relevant provisions of applicable law and subject to approval of the Company's shareholders and receipt of applicable regulatory approvals. Thanking You.08-12-2020
POLY MEDICURE LTD. - 531768 - Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On 8Th December, 2020
POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/12/2020 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(d) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, (the ''Listing Regulations'') a meeting of the board of directors of the Company is scheduled to be held on Tuesday, 8th December, 2020 to inter alia, to consider and approve the proposal of fund raising by way of debts, equity shares, convertible/non-convertible securities or other equity linked securities on preferential basis/private placement basis, for such amount and on such terms and conditions as may be decided by the Board of Directors at the aforesaid meeting. In accordance with the applicable Regulations of SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company will remain closed for Officers, Designated Employees and Connected Persons, till 48 (Forty Eight) hours after the conclusion of Board meeting. This is for your information and record.30-11-2020
POLY MEDICURE LTD. - 531768 - Disclosure Of Related Party Transactions For The Half Year Ended On 30Th September, 2020 In Compliance Of Regulation 23(9) Of SEBI (LODR) Regulations, 2015
Dear Sir/Madam, Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, pleased find enclosed herewith disclosure of Related Party Transactions drawn in accordance with applicable Accounting Standards for the half-year ended on 30th September, 2020. Kindly take a note of the same for your further needful and oblige us.18-11-2020
POLY MEDICURE LTD. - 531768 - Outcome Of The Board Meeting Of The Company
Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, we are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 26th October, 2020, at 232-B, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi-110020 has approved. a) Standalone and Consolidated Un-Audited Financial Results along with Limited Review Report for the quarter and half year ended on 30th September, 2020. b) Other Routine Businesses We request you to take the above on record and the same be treated as the necessary compliance under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Thanking You,26-10-2020